MC
TMO icon

Moors & Cabot’s Thermo Fisher Scientific TMO Stock Holding History

Moors & Cabot’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,119
Closed -$29K – 700
2019
Q3 		$29K Buy
+10,119
New +$2.9M ﹤0.01% 635

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Moors & Cabot's TMO Position: Q2 2026 in Review

Moors & Cabot reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $220K and leaving 2,681 shares worth $1.34M. The position accounts for 0.05% of the portfolio, ranked #317.

Moors & Cabot first reported a position in TMO in Q3 2015 and has held it in 44 quarters since. The position peaked at $3.98M in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Moors & Cabot held 2,681 shares of Thermo Fisher Scientific worth $1.34M as of Q2 2026.
  • Moors & Cabot sold 458 Thermo Fisher Scientific shares in Q2 2026, an estimated $220K.
  • Thermo Fisher Scientific made up 0.05% of Moors & Cabot's portfolio in Q2 2026, its #317 holding.
  • Moors & Cabot first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 44 quarters since.
  • Moors & Cabot's Thermo Fisher Scientific position peaked at $3.98M in Q4 2021.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.